Fibrobesity – Preventing Fibrosis Related to Obesity
Fibrobesity – Preventing Fibrosis Related to Obesity - is a multidisciplinary research programme supported by the Research Council of Finland PROFI6 funding from 2021-2026. The focus of the Fibrobesity study is on the medical and societal challenges of obesity-related fibrotic pathologies. The Fibrobesity research community extends to several faculties and research areas from medicine, biochemistry, and molecular medicine to human, education, and ICT sciences.
Fibrobesity links strongly with the strategy of the University of Oulu under a wider umbrella of FibroHealth – Combatting Fibrosis in Chronic Diseases. Research on FibroHealth generally addresses fibrosis as a risk factor in the etiology of complex chronic diseases and unhealthy aging.
Fibrobesity links strongly with the strategy of the University of Oulu under a wider umbrella of FibroHealth – Combatting Fibrosis in Chronic Diseases. Research on FibroHealth generally addresses fibrosis as a risk factor in the etiology of complex chronic diseases and unhealthy aging.
The world-class research at the University of Oulu on hypoxia and extracellular matrix (ECM) together with cutting-edge research on obesity, cardiovascular risk factors, metabolic syndrome, polycystic ovary syndrome, and other fibrosis-related diseases, combined with our unique population and patient cohort studies and state-of-the-art research infrastructure, form the basis of Fibrobesity.
The Fibrobesity Research Programme publishes a regular newsletter every two months. We have put together an archive of our old newsletters here. The latest newsletters will also be added to the archive shortly after publication. We warmly welcome you to get to know our community!
The newsletter publication dates for 2024 are:
- 14 February,
- 10 April,
- 12 June,
- 21 August,
- 9 October and
- 11 December.